Cargando…
TRIM32 promotes proliferation and confers chemoresistance to breast cancer cells through activation of the NF-κB pathway
Dysregulation of TRIM32 has been implicated in several human cancers, however, its clinical significance and biological function in breast cancer have not been investigated. Using immunohistochemistry, we found that TRIM32 expression is upregulated in breast cancer tissues and that it correlates wit...
Autores principales: | Zhao, Ting-Ting, Jin, Feng, Li, Ji-Guang, Xu, Ying-Ying, Dong, Hui-Ting, Liu, Qun, Xing, Peng, Zhu, Guo-Lian, Xu, Hao, Yin, Song-Cheng, Miao, Zhi-Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5929078/ https://www.ncbi.nlm.nih.gov/pubmed/29721043 http://dx.doi.org/10.7150/jca.22390 |
Ejemplares similares
-
TRIM31 promotes glioma proliferation and invasion through activating NF-κB pathway
por: Zhou, Li, et al.
Publicado: (2019) -
SseK3 Is a Salmonella Effector That Binds TRIM32 and Modulates the Host’s NF-κB Signalling Activity
por: Yang, Zhe, et al.
Publicado: (2015) -
SMYD3 confers cisplatin chemoresistance of NSCLC cells in an ANKHD1-dependent manner
por: Lv, Hong-Wei, et al.
Publicado: (2021) -
SOX13/TRIM11/YAP axis promotes the proliferation, migration and chemoresistance of anaplastic thyroid cancer
por: Tang, Jianing, et al.
Publicado: (2021) -
TRIM32 overexpression improves chemoresistance through regulation of mitochondrial function in non-small-cell lung cancers
por: Du, Yaming, et al.
Publicado: (2018)